BTG3 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
fibroblast	28 studies	31% ± 15%	Explore
pericyte	19 studies	28% ± 12%	Explore
regulatory T cell	17 studies	24% ± 9%	Explore
smooth muscle cell	15 studies	33% ± 11%	Explore
endothelial cell	14 studies	21% ± 6%	Explore
basal cell	14 studies	40% ± 16%	Explore
connective tissue cell	13 studies	26% ± 16%	Explore
epithelial cell	13 studies	40% ± 21%	Explore
CD8-positive, alpha-beta T cell	11 studies	26% ± 10%	Explore
type I pneumocyte	10 studies	37% ± 16%	Explore
type II pneumocyte	10 studies	37% ± 18%	Explore
CD4-positive, alpha-beta T cell	10 studies	21% ± 5%	Explore
ciliated cell	10 studies	38% ± 15%	Explore
T cell	9 studies	23% ± 5%	Explore
natural killer cell	9 studies	23% ± 6%	Explore
myofibroblast cell	9 studies	30% ± 16%	Explore
secretory cell	8 studies	52% ± 12%	Explore
leukocyte	6 studies	25% ± 6%	Explore
club cell	6 studies	32% ± 13%	Explore
macrophage	6 studies	21% ± 5%	Explore
endothelial cell of vascular tree	6 studies	22% ± 7%	Explore
gamma-delta T cell	6 studies	26% ± 9%	Explore
mast cell	5 studies	26% ± 10%	Explore
effector memory CD8-positive, alpha-beta T cell	5 studies	24% ± 11%	Explore
mature NK T cell	5 studies	18% ± 4%	Explore
abnormal cell	5 studies	27% ± 8%	Explore
CD8-positive, alpha-beta memory T cell	5 studies	24% ± 5%	Explore
oligodendrocyte precursor cell	5 studies	24% ± 7%	Explore
B cell	4 studies	21% ± 3%	Explore
deuterosomal cell	4 studies	64% ± 10%	Explore
pancreatic A cell	4 studies	32% ± 14%	Explore
type B pancreatic cell	4 studies	60% ± 22%	Explore
CD16-positive, CD56-dim natural killer cell, human	4 studies	19% ± 2%	Explore
renal alpha-intercalated cell	4 studies	30% ± 3%	Explore
myeloid cell	4 studies	26% ± 6%	Explore
dendritic cell	4 studies	25% ± 5%	Explore
goblet cell	4 studies	26% ± 7%	Explore
pancreatic D cell	3 studies	54% ± 20%	Explore
placental villous trophoblast	3 studies	70% ± 10%	Explore
mucosal invariant T cell	3 studies	20% ± 2%	Explore
precursor B cell	3 studies	27% ± 9%	Explore
pro-B cell	3 studies	22% ± 3%	Explore
lymphocyte	3 studies	24% ± 8%	Explore
erythrocyte	3 studies	30% ± 17%	Explore
luminal hormone-sensing cell of mammary gland	3 studies	27% ± 5%	Explore
T follicular helper cell	3 studies	22% ± 6%	Explore
plasmacytoid dendritic cell	3 studies	21% ± 8%	Explore
keratinocyte	3 studies	34% ± 12%	Explore
progenitor cell of mammary luminal epithelium	3 studies	26% ± 7%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
lung	11 studies	27% ± 10%	Explore
pancreas	4 studies	41% ± 14%	Explore
kidney	4 studies	19% ± 1%	Explore
placenta	4 studies	33% ± 12%	Explore
uterus	4 studies	32% ± 12%	Explore
prostate	3 studies	51% ± 13%	Explore
brain	3 studies	20% ± 5%	Explore
liver	3 studies	30% ± 19%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
esophagus	100%	1326.94	1445 / 1445	100%	51.97	183 / 183
thymus	100%	2002.35	653 / 653	100%	64.33	604 / 605
lung	100%	3081.75	577 / 578	100%	72.26	1151 / 1155
ovary	100%	1840.36	180 / 180	99%	107.74	427 / 430
uterus	100%	2725.44	170 / 170	99%	86.35	455 / 459
bladder	100%	1390.52	21 / 21	98%	51.74	496 / 504
stomach	100%	1131.16	359 / 359	98%	35.64	281 / 286
adrenal gland	100%	1653.36	258 / 258	97%	39.31	224 / 230
intestine	100%	1540.82	966 / 966	97%	36.98	513 / 527
skin	100%	2470.79	1809 / 1809	95%	44.41	450 / 472
prostate	100%	1784.42	245 / 245	93%	23.94	469 / 502
pancreas	94%	722.63	308 / 328	98%	37.87	174 / 178
breast	100%	1719.53	459 / 459	86%	31.58	958 / 1118
kidney	100%	1379.70	89 / 89	83%	27.09	747 / 901
brain	78%	765.32	2059 / 2642	99%	48.72	700 / 705
liver	38%	208.33	85 / 226	74%	16.73	302 / 406
lymph node	0%	0	0 / 0	100%	30.78	29 / 29
spleen	100%	971.77	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	78.30	45 / 45
ureter	0%	0	0 / 0	100%	11.33	1 / 1
adipose	100%	1733.53	1202 / 1204	0%	0	0 / 0
blood vessel	100%	1745.50	1331 / 1335	0%	0	0 / 0
eye	0%	0	0 / 0	95%	38.18	76 / 80
heart	80%	874.13	688 / 861	0%	0	0 / 0
peripheral blood	42%	661.50	392 / 929	0%	0	0 / 0
muscle	16%	71.00	125 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0008285	Biological process	negative regulation of cell population proliferation
GO_0045930	Biological process	negative regulation of mitotic cell cycle
GO_0005737	Cellular component	cytoplasm
GO_0005634	Cellular component	nucleus
GO_0005515	Molecular function	protein binding

IV. Literature review

[source]

Gene name	BTG3
Protein name	Protein BTG3 BTG family, member 3, isoform CRA_b (BTG3 protein) (cDNA FLJ75072, highly similar to Homo sapiens BTG family, member 3 (BTG3), mRNA) BTG anti-proliferation factor 3 (Protein BTG3) Protein BTG3 (Abundant in neuroepithelium area protein) (BTG family member 3) (Protein Tob5)
Synonyms	ANA TOB5 hCG_401161
Description	FUNCTION: Overexpression impairs serum-induced cell cycle progression from the G0/G1 to S phase.
Accessions	A0A0G2JRT0 ENST00000457956.1 ENST00000339775.10 [Q14201-2] ENST00000629582.1 ENST00000628349.1 Q14201 C9JLA2 ENST00000348354.7 [Q14201-1] A0A0G2JRS5 Q6IAU3 ENST00000627237.2

BTG3 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review